Mia Golder

Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation

Tanja Kosenko, Mia Golder, Geoffrey Leblond et al. · Journal of Biological Chemistry · 2013 · 180 citations · Full text

Ldlr Degradation, Immunology, Hyperlipidemia +16

Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models

Cynthia M. Pruss, Mia Golder, Andrea Bryant et al. · Blood · 2011 · 50 citations · Full text

Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions

Mia Golder, Cynthia M. Pruss, Carol Hegadorn et al. · Blood · 2010 · 42 citations · Full text

In vitro and in vivo evaluation of the effect of elevated factor VIII on the thrombogenic process

Mia Golder, Jeffrey Mewburn, David Lillicrap · Thrombosis and Haemostasis · 2012 · 27 citations · Full text

Immunology, Pathology, Inflammation +22

Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W

Cynthia M. Pruss, Mia Golder, Andrea Bryant et al. · Journal of Thrombosis and Haemostasis · 2012 · 21 citations · Full text

Knockout Mouse, Molecular Physiology, Natural Sciences +9